$6.52
2.3255.24%
al cierre: Sep 28, 5:00 PM EST
$6.61
0.091.38%
After hour: 7:46 PM EST
Lifecore Biomedical Inc
LFCRNASDAQ
PRO
Fusiones y adquisiciones: Lifecore Biomedical (LFCR) announced it will be acquired by Webster Equity Partners on Monday, September 28, 2026 for $663.7M paid in cash
Lifecore Biomedical Earnings & Forecasts
Lifecore Biomedical (LFCR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Lifecore Biomedical Guidance
Lifecore Biomedical (LFCR) publicó su última previsión de agosto 5, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $120M - $125M para el período.
En comparación con la previsión anterior, Lifecore Biomedical mantenido redujo su previsión de ingresos desde un rango anterior de $120M - $125M.
Lifecore Biomedical ha emitido 7 actualizaciones de orientación entre el abril 1, 2024 y el agosto 5, 2026. During this period, the company lowered its outlook 1 time, signaling management's revised expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.21 | $-0.28 | — | $-0.30 |
| Actual | $-0.19 | $-0.43 | $-0.16 | $-0.29 |
| Surprise | +9.52% | -53.6% | — | +3.33% |
| Revenue | ||||
| Estimate | $32.1M | $26.3M | — | $26.6M |
| Actual | $34.2M | $23.2M | $35.7M | $31.1M |
| Surprise | +6.71% | -11.8% | — | +17.2% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.30 | $-0.10 | $-0.30 | $-0.22 |
| Revenue | ||||
| Consensus | $25.6M | $38.4M | — | — |